Effects of dapagliflozin in patients with membranous nephropathy

Chertow, G. M. et al. (2024) Effects of dapagliflozin in patients with membranous nephropathy. Glomerular Diseases, (Accepted for Publication)

[img] Text
327728.pdf - Accepted Version
Restricted to Repository staff only

305kB

Abstract

No abstract available.

Item Type:Articles
Keywords:Chronic kidney disease, dapagliflozin, estimated glomerular filtration rate, membranous nephropathy, sodium-glucose cotransporter 2 inhibitor.
Status:Accepted for Publication
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mark, Professor Patrick
Authors: Chertow, G. M., Heerspink, H. L., Mark, P. B., Dwyer, J. P., Nowickig, M., Wheeler, D. C., Correa-Rotter, R., Rossing, P., Toto, R. D., Langkilde, A. M., and Jongs, N.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Glomerular Diseases
Publisher:Karger
ISSN:2673-3625
ISSN (Online):2673-3633

University Staff: Request a correction | Enlighten Editors: Update this record